TREATMENT OF TINNITUS
Defines Priority Health's coverage determinations for management of chronic subjective bothersome tinnitus, specifying medically necessary interventions, investigational/not medically necessary treatments (including TRT, CBT, neuromodulation, sound therapy, acupuncture, etc.), limits related to hearing aid rider, and CMS/LCD references. This is part 1 of 2 and covers background, evidence summaries, inclusions, exclusions, and limitations.
Added evidence-supported management inclusions, such as patient education, audiologic evaluation, hearing aids when indicated, and pharmacologic treatment of comorbid conditions.
Added a clear experimental/investigational exclusions list, including brain implant, CBT as a tinnitus treatment, sound therapy, neuromodulation, acupuncture, biofeedback, and other alternative or device-based therapies.
Added structured sections for society guidelines, CMS considerations, and FDA context.
Updated the policy title and structure to reflect a comprehensive tinnitus management framework.
Expanded and updated the background and references to reflect current evidence and guidelines.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.